Skip to main content
PRE logo

PRE · Prenetics Global Ltd

Track PRE — free
$19.37 -0.38 (-1.92%) At close · Aug 17 Earnings today
Market Cap
$333.26M
Shares
16.87M

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Upcoming events

Date Event Type
2026-08-18 12:30 UTC Prenetics Global Limited 2Q26 Earnings Call Earnings call

Recent news

Date Headline
2026-08-17 Prenetics, Parent of IM8, Appoints II Ranked, Caroline Levy, Veteran Wall Street Consumer Analyst as Independent Director

30+ years as one of Wall Street’s top-ranked equity research consumer analysts, including leadership of U.S. consumer research at UBS Caroline will also serve on the Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee.

2026-08-07 Prenetics to Report Q2 2026 Financial Results on August 18, 2026, Live-Stream Earnings Event on Stocktwits, and Announces Upcoming Conference Participation

NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading consumer health company and parent of the AI-native direct-to-consumer wellness brand IM8, co-founded by David Beckham, today announced it will release financial results for

2026-07-14 Prenetics’ IM8 Secures $1 Billion Growth Financing from General Catalyst’s Customer Value Fund (CVF)

IM8 is the fastest-growing premium supplement brand ever recorded — over 50 million servings delivered to date, with approximately 200,000 servings currently delivered daily, and an order every 27 seconds Prenetics raises full-year 2026 IM8 revenue guidance to $210–220 million, up from $190–210

2026-06-10 Prenetics Announces Record Q1 2026 Results with IM8 Revenue Reaching a Record ~$16.7 Million in May, Implying ~$200 Million in Annualized Recurring Revenue

Q1 2026 revenue of $36.0 million with IM8 revenue of $33.8 million, up 23.1% from IM8 revenue of $27.4 million in Q4 2025 and nearly 6x year-over-year from IM8 revenue of $5.7 million in Q1 2025 Raises full-year 2026 IM8 revenue guidance to $190 million to $210 million (previously $180 million to

2026-06-04 Prenetics Appoints Hudson Leogrande, Founder and CEO of Multi-Billion-Dollar DTC Brand Comfrt, to Board of Directors as IM8 Accelerates TikTok and Meta Expansion

Hudson Leogrande is the Founder and CEO of Comfrt — a multi-billion-dollar DTC brand projected to exceed $1 billion in revenue in 2026 Comfrt is one of the largest advertisers on both TikTok and Meta; Comfrt’s 600,000-strong TikTok affiliate community drives organic cultural reach that unlocks Meta

2026-05-20 Prenetics Announces Jay Shetty as IM8 Global Ambassador and Shareholder in Multi-Year Partnership

Multi-year partnership lands as Prenetics’ IM8 raises full-year 2026 revenue guidance to $190 million to $210 million following nearly 6x year-over-year growth in Q1 2026 Shetty is IM8’s first global ambassador from outside the world of sport Joins an equity-aligned roster of David Beckham, Giannis

2026-05-14 Prenetics Welcomes Brian J. Rosin as Chief Financial Officer of IM8

~ Two-decade veteran of premium consumer health, nutrition, and direct-to-consumer brands joins IM8 to support its rapid global expansion NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), the parent company of IM8, the premium health

2026-05-14 Prenetics Announces Preliminary Record Q1 2026 Results with IM8 Revenue Growing Nearly 6x YoY; Company Raises Full-Year 2026 IM8 Revenue Guidance to $190M–$210M

Prenetics records Q1 2026 revenue of $36.0 million with IM8 revenue of $33.8 million, up 23.1% from IM8 revenue of $27.4 million in Q4 2025 Raises full-year 2026 IM8 revenue guidance to $190 million to $210 million (previously $180 million to $200 million) Company projects Q2 2026 revenue of $46

2026-05-08 Prenetics to Report Q1 2026 Financial Results on May 14, 2026 and Host Earnings Conference Call

NEW YORK, May 08, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), the parent company of IM8, the premium health and longevity brand co-founded with David Beckham, today announced it will release financial results for the first quarter 2026 ended March

2026-05-07 Prenetics’ IM8 Named Exclusive Health Supplements Partner of Inter Miami CF in Multi-Year Partnership

IM8 products, including Daily Ultimate Essentials, Daily Ultimate Longevity, and The Beckham Stack, to be integrated into Inter Miami’s training facility and made available to all players NEW YORK and MIAMI, May 07, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the

2026-04-14 Prenetics’ IM8 Health Partners with Vitamin Angels to Combat Global Malnutrition, Commits to Impacting 400,000 Mothers and Children in Year One

Partnership Extends IM8’s Mission Beyond Premium Nutrition to Address Malnutrition Among the World’s Most Vulnerable Populations Long-Term Goal to Impact Millions of Lives Through Sustained Funding and Awareness Vitamin Angels Reaches Over 74 Million Women and Children Annually Across 65+ Countries

2026-04-02 Prenetics Announces NBA Champion and Two-Time MVP Giannis Antetokounmpo as IM8 Global Partner and Shareholder in Multi-Year Partnership

Giannis becomes the first NBA athlete shareholder in a NASDAQ-listed health and longevity brand, joining the fastest supplement company ever to reach $100M ARR in just 11 months Giannis unlocks 35 million followers across social channels - NBA broadcasted in 215 countries To learn more about

2026-03-24 Prenetics' IM8 Partners with Superpower to Personalize the Future of Supplementation

IM8 90-Day Subscribers Unlock SuperPower Blood Testing for $49 — A 75% Saving on the Standard $199 Price. IM8 and Superpower create the first closed-loop system in consumer health – connecting clinical-grade supplementation with 100+ biomarker blood testing.

Past events

Source: https://ir.prenetics.com/

Key facts CIK 1876431 CUSIP G72245122 13F (30d) 34 filings 34 filers Visit website Investor relations